These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 34032492)

  • 1. Patterns of Recurrence following Inguinal Lymph Node Dissection for Penile Cancer: Optimizing Surveillance Strategies.
    Chakiryan NH; Dahmen A; Bandini M; Pederzoli F; Marandino L; Albersen M; Roussel E; Zhu Y; Ye DW; Ornellas AA; Catanzaro M; Hakenberg OW; Heidenreich A; Haidl F; Watkin N; Ager M; Chahoud J; Briganti A; Salvioni R; Montorsi F; Necchi A; Spiess PE
    J Urol; 2021 Oct; 206(4):960-969. PubMed ID: 34032492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Penile Squamous Cell Carcinoma Patients Undergoing Inguinal Lymph Node Dissection.
    Azizi M; Peyton CC; Boulware DC; Chipollini J; Juwono T; Pow-Sang JM; Spiess PE
    Eur Urol Focus; 2019 Nov; 5(6):1085-1090. PubMed ID: 29937330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of inguinal lymph node dissection in men with urethral squamous cell carcinoma.
    Werntz RP; Riedinger CB; Fantus RJ; Smith ZL; Packiam VT; Adamsky MA; Smith N; Steinberg GD
    Urol Oncol; 2018 Dec; 36(12):526.e1-526.e6. PubMed ID: 30446445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph node density predicts recurrence and death after inguinal lymph node dissection for penile cancer.
    Ball MW; Schwen ZR; Ko JS; Meyer A; Netto GJ; Burnett AL; Bivalacqua TJ
    Investig Clin Urol; 2017 Jan; 58(1):20-26. PubMed ID: 28097264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and survival outcomes for upstaging after inguinal lymph node dissection for cN1 penile squamous cell carcinoma.
    Chakiryan NH; Dahmen A; Bandini M; Pederzoli F; Marandino L; Albersen M; Roussel E; Zhu Y; Ye DW; Ornellas AA; Catanzaro M; Hakenberg OW; Heidenreich A; Haidl F; Watkin N; Ager M; Briganti A; Salvioni R; Montorsi F; Necchi A; Spiess PE
    Urol Oncol; 2021 Dec; 39(12):838.e7-838.e13. PubMed ID: 34602362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risks and Benefits of Adjuvant Radiotherapy After Inguinal Lymphadenectomy in Node-positive Penile Cancer: A Systematic Review by the European Association of Urology Penile Cancer Guidelines Panel.
    Robinson R; Marconi L; MacPepple E; Hakenberg OW; Watkin N; Yuan Y; Lam T; MacLennan S; Adewuyi TE; Coscione A; Minhas SS; Compérat EM; Necchi A
    Eur Urol; 2018 Jul; 74(1):76-83. PubMed ID: 29703686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penile carcinoma (pT1 G2): surveillance or inguinal lymph node dissection?
    Naumann CM; Filippow N; Seif C; van der Horst C; Roelver L; Braun PM; Juenemann KP; Portillo FJ
    Onkologie; 2005 Mar; 28(3):135-8. PubMed ID: 15772463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying an optimal lymph node yield for penile squamous cell carcinoma: prognostic impact of surgical dissection.
    Chipollini J; Azizi M; Lo Vullo S; Mariani L; Zhu Y; Ye DW; Ornellas AA; Watkin N; Ager M; Hakenberg O; Heidenreich A; Raggi D; Catanzaro M; Ornellas P; Salvioni R; Cheriyan SK; Necchi A; Spiess PE
    BJU Int; 2020 Jan; 125(1):82-88. PubMed ID: 31356716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph Node Mapping in Patients with Penile Cancer Undergoing Pelvic Lymph Node Dissection.
    Yao K; Chen Y; Ye Y; Wu Z; Chen D; Han H; Li Z; Liu Z; Wang Y; Qin Z; Li Y; Li Z; Zhou F
    J Urol; 2021 Jan; 205(1):145-151. PubMed ID: 32755338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of the lymph nodes in penile cancer.
    Heyns CF; Fleshner N; Sangar V; Schlenker B; Yuvaraja TB; van Poppel H
    Urology; 2010 Aug; 76(2 Suppl 1):S43-57. PubMed ID: 20691885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral inguinal lymph-node dissection vs. unilateral inguinal lymph-node dissection and dynamic sentinel node biopsy in clinical N1 squamous cell carcinoma of the penis.
    Nazzani S; Catanzaro M; Biasoni D; Maccauro M; Stagni S; Torelli T; Macchi A; Bernasconi V; Taverna A; Sessa D; Lorenzoni A; Piva L; Lanocita R; Cascella T; Cattaneo L; Montanari E; Salvioni R; Nicolai N
    Urol Oncol; 2023 Apr; 41(4):210.e1-210.e8. PubMed ID: 36868883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immediate Inguinal Lymph Node Dissection Improves Survival in Patients of Penile Cancer].
    Wang HZ; Liu ZH; Liu JB; Ren SQ; Zhao T; Zeng H; Li X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 May; 47(3):371-5. PubMed ID: 27468483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node yield as a predictor of overall survival following inguinal lymphadenectomy for penile cancer.
    Soodana-Prakash N; Koru-Sengul T; Miao F; Lopategui DM; Savio LF; Moore KJ; Johnson TA; Alameddine M; Barboza MP; Parekh DJ; Punnen S; Gonzalgo ML; Ritch CR
    Urol Oncol; 2018 Oct; 36(10):471.e19-471.e27. PubMed ID: 30143385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant vs Staged Therapeutic Inguinal Lymphadenectomy in Clinically Node Positive Penile Squamous Cell Carcinoma: Does It Make a Difference?
    Huelster HL; Chang A; Rose KM; Bandini M; Albersen M; Roussel E; Chipollini J; Zhu Y; Ye DW; Ornellas AA; Catanzaro M; Marandino L; Pederzoli F; Hakenberg OW; Heidenreich A; Haidl F; Watkin N; Ager M; Ahmed ME; Karnes JR; Briganti A; Kim Y; Montorsi F; Necchi A; Spiess PE
    J Urol; 2023 Mar; 209(3):557-564. PubMed ID: 36652397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term followup of penile carcinoma with high risk for lymph node invasion treated with inguinal lymphadenectomy.
    Marconnet L; Rigaud J; Bouchot O
    J Urol; 2010 Jun; 183(6):2227-32. PubMed ID: 20399455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with regional recurrence after lymph node dissection for penile squamous cell carcinoma.
    Reddy JP; Pettaway CA; Levy LB; Pagliaro LC; Tamboli P; Rao P; Jayaratna I; Hoffman KE
    BJU Int; 2017 Apr; 119(4):591-597. PubMed ID: 27753187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph node metastasis in intermediate-risk penile squamous cell cancer: a two-centre experience.
    Hughes BE; Leijte JA; Kroon BK; Shabbir MA; Swallow TW; Heenan SD; Corbishley CM; van Boven HH; Perry MJ; Watkin NA; Horenblas S
    Eur Urol; 2010 Apr; 57(4):688-92. PubMed ID: 19647926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a benefit to adjuvant radiation in stage III penile cancer after lymph node dissection? Findings from the National Cancer Database.
    Winters BR; Kearns JT; Holt SK; Mossanen M; Lin DW; Wright JL
    Urol Oncol; 2018 Mar; 36(3):92.e11-92.e16. PubMed ID: 29174944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk factors for the presence of pelvic lymph node metastasis in penile squamous cell carcinoma patients with inguinal lymph node dissection.
    Liu JY; Li YH; Zhang ZL; Yao K; Ye YL; Xie D; Han H; Liu ZW; Qin ZK; Zhou FJ
    World J Urol; 2013 Dec; 31(6):1519-24. PubMed ID: 23455885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usage and survival implications of surgical staging of inguinal lymph nodes in intermediate- to high-risk, clinical localized penile cancer: A propensity-score matched analysis.
    Woldu SL; Ci B; Hutchinson RC; Krabbe LM; Singla N; Passoni NM; Clinton TN; Raj GV; Miller DS; Sagalowsky AI; Lotan Y; Xie Y; Margulis V; Bagrodia A
    Urol Oncol; 2018 Apr; 36(4):159.e7-159.e17. PubMed ID: 29288008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.